Our ancestors were healthy by default because their environment promoted it. Today, the default environment—filled with processed foods, sedentary lifestyles, and novel chemicals—systematically produces unhealthy people, making good health an uphill battle of individual effort against the system.
The scale of America's health crisis—with over 75% of adults overweight or obese—is equivalent to a successful bioweapon attack by an adversary. This framing suggests the problem requires the urgency and resource mobilization of a national security threat, not just a healthcare policy discussion.
While GLP-1 drugs can jumpstart weight loss by reducing appetite, they don't address poor food quality. If users simply eat less ultra-processed food, they risk severe protein and micronutrient deficiencies, leading to different long-term health consequences.
TrueMed's model allows consumers to use tax-free HSA/FSA funds for preventative health measures like gym memberships and healthy food. By facilitating a "letter of medical necessity," it effectively reclassifies these lifestyle interventions as legitimate medical expenses, creating a financial incentive for prevention.
The emerging field of "metabolic psychiatry" suggests many mental health conditions are rooted in physical, metabolic dysfunction. Interventions focused on reducing inflammation, improving gut health, and specific diets (e.g., ketogenic for epilepsy) can be more effective than traditional psychological treatments.
Government subsidies for corn, soy, and wheat make these crops artificially cheap. Food manufacturers then overuse them in processed forms like high-fructose corn syrup and soybean oil, which have become staples in the American diet and are a root cause of chronic disease.
Unlike the EU's strict approval process for new chemicals, the U.S. allows companies to self-declare novel compounds as "Generally Recognized as Safe" (GRAS). This has resulted in tens of thousands of chemicals in the U.S. food system that are not permitted in the EU, contributing to the chronic disease crisis.
The 1970s marked a shift where major food corporations, driven by market pressure, began systematically replacing natural ingredients with cheaper, ultra-processed substitutes. This move, aimed at boosting earnings per share, created the foundation for today's 'poisonous' food system and rising chronic disease.
Peptides represent a disruptive class of compounds that focus on enhancement (more energy, better gut health) rather than disease management (e.g., statins). Because they are often unpatentable and cheap, they challenge the existing pharmaceutical industry's business model, which is built on patented drugs for chronic conditions.